LENZ Therapeutics, Inc.
LENZ
$29.73
$0.852.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -49.77M | -60.81M | -69.47M | -73.95M | -69.97M |
| Total Depreciation and Amortization | 58.00K | 37.00K | 31.00K | 17.00K | 15.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.41M | 2.93M | 2.17M | 1.72M | 163.00K |
| Change in Net Operating Assets | -13.09M | -13.44M | -6.52M | 686.00K | 9.41M |
| Cash from Operations | -59.39M | -71.28M | -73.79M | -71.52M | -60.38M |
| Capital Expenditure | -468.00K | -319.00K | -133.00K | -24.00K | -30.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -154.01M | -127.12M | -83.00M | -11.59M | -29.59M |
| Cash from Investing | -154.48M | -127.44M | -83.13M | -11.62M | -29.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 83.70M | 83.65M | 53.82M | 53.82M | 203.00K |
| Repurchase of Common Stock | -150.00K | -150.00K | -150.00K | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | 82.98M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 115.45M | 113.54M | 112.99M | 114.97M | -2.48M |
| Cash from Financing | 199.00M | 197.04M | 166.65M | 168.79M | 80.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.87M | -1.69M | 9.73M | 85.66M | -9.30M |